3680-69-1Relevant articles and documents
Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents
Patil, Yogesh,Shingare, Ramesh,Choudhari, Amit,Borkute, Rachana,Sarkar, Dhiman,Madje, Balaji R.
, (2018)
A series of new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidines 8a–l were synthesized and characterized by IR, NMR (1H and 13C), and mass spectral analysis. The newly synthesized compounds 8a–l were inspected for their in vitro antitubercular activity against Mycobacterium tuberculosis (MTB) H37Ra using an established XTT reduction menadione assay (XRMA). The title compounds exhibited minimum inhibitory concentrations (MIC90) ranging from 0.09 to >30 μg/mL. Five compounds (8c, 8i–l) were further confirmed for their dose-dependent effect against MTB. These compounds were evaluated in the THP-1 infection model, where 8i (MIC90 = 0.35 μg/mL), 8j (MIC90 = 1.17 μg/mL), 8k (MIC90 = 2.38 μg/mL), and 8l (MIC90 = 1.17 μg/mL) demonstrated significant antitubercular activity. All the ex vivo active compounds showed insignificant cytotoxicity against the human cancer cell lines, HeLa, MCF-7, and THP-1. Inactivity of all these compounds against Gram positive and Gram negative bacteria indicates their specificity. Molecular docking studies in the active site of the sterol 14alpha-demethylase (CYP51) enzyme revealed a similar binding mode to the native ligand in the crystal structure, thereby helping to understand the ligand–protein interactions and to establish a structural basis for inhibition of MTB. The results suggest novel pharmacophores as selective and specific inhibitors against MTB that can be explored further to synthesize lead compounds against tuberculosis. In summary, the results clearly indicate the identification of some novel, selective, and specific inhibitors against MTB that can be explored further for potential antitubercular drugs.
Production process 4 -chloropyrrolo [2, 3 - d] pyrimidine
-
Paragraph 0037-0038; 0040-0041; 0043; 0046-0049; 0051-0052, (2021/10/27)
The production process of 4 - chloropyrrolo [2, 3 - d] pyrimidine comprises the following steps: S1, adding the compound I and the compound II to the mixed solvent I, carrying out temperature rise reaction under the catalysis of the base I to obtain the compound III. S2, sodium alkoxide I was added to alcoholic solvent II, compound IV and compound III were added to raise the temperature, and organic solvent III, organic solvent IV and compound V were added to raise the temperature to give 4 - chloropyrrolo [2, 3 - d] pyrimidine crude product. Among them, compound I is. . Compound II was obtained. . Compound III was obtained. . The compound IV is formamidine. Compound V was POCl. 3 To the method, bromoacetaldehyde dimethyl acetal and cyanoethyl acetate are subjected to reflux reaction, and 2 - cyano -4, 4 - methoxybutyric acid ethyl ester and formamidine acetate are subjected to one-pot chlorofluorination reaction, so that the reaction period is greatly shortened.
Production system of medical intermediate 4-chloropyrrolopyrimidine
-
Paragraph 0019; 0021-0025; 0029-0040, (2020/03/06)
The invention discloses a production system of medical intermediate 4-chloropyrrolopyrimidine. The production system is used for a novel production process of 4-chloropyrrolopyrimidine by taking pyrrolo[2,3-d]pyrimidin-4-ol as a reaction substrate, and comprises a high-temperature and high-pressure stirring reaction kettle for preparing 4-chloropyrrolopyrimidine by taking pyrrolo[2,3-d]pyrimidin-4-ol as a substrate; the top of the high-temperature and high-pressure stirring reaction kettle is connected with an alkali liquor pool for absorbing tail gas through a pipeline with a valve; the bottom of the high-temperature and high-pressure stirring reaction kettle is connected with a distillation tower used for evaporating a solvent through a pipeline; the distillation tower is connected witha condenser used for condensing solvent steam and a washing kettle used for washing an obtained product; the condenser is connected with a solvent recovery tank used for recovering the solvent; and the washing kettle is connected with a suction filtration barrel used for separating a solid product. Because a large amount of POCl3 does not need to be used in a new production method, the quenching process is safe, the whole set of device is closed, little toxic gas is discharged, and the purpose of green production can be achieved.
Synthetic method of medical intermediate 4-chloropyrrolopyrimidine
-
Paragraph 0020; 0027-0028; 0030-0033; 0035, (2020/02/14)
The invention discloses a synthetic method of a medical intermediate, i.e., 4-chloropyrrolopyrimidine. The synthetic method comprises the following steps: with 4-hydroxypyrrolo[2, 3-d]pyrimidine as areaction substrate and a mixed solution of NMP/methylbenzene as a solvent; adding 2.0 to 4.0 equivalents of 1,2,3-trichloropropane into a reaction kettle, carrying out a refluxing and stirring reaction for 4-5 h at 100-120 DEG C in a chlorine environment, carrying out vucummizing at 160-180 DEG C to evaporate excessive solvent so as to obtain an oily substance, starting stirring, adding a sodium hydroxide solution with a concentration of 0.5-1mol/L into the oily substance, and performing filtering and drying to obtain the 4-chloropyrrolopyrimidine product. POCl3 is replaced by using the novelmethod, so the problems of quenching danger and low working efficiency of conventional synthesis methods are solved.
Method for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidine by adopting non-phosphorus chlorination reagent
-
Paragraph 0062-0071, (2020/08/25)
The invention discloses a method for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidine from a non-phosphorus chlorination reagent, which is technically characterized by comprising the following steps: 1)preparing a Vilsmeier reagent from a non-phosphorus reagent and N,N-dimethylformamide (DMF) in an aprotic solvent; and 2) adding 4-hydroxy-7H-pyrrolo[2,3-d]pyrimidine into the prepared Vilsmeier reagent, and carrying out a chlorination reaction to generate the 4-chloro-7H-pyrrolo[2,3-d]pyrimidine. The objective of the invention is to provide the method for preparing the 4-chloro-7H-pyrrolo[2,3-d]pyrimidine by using the non-phosphorus chlorination reagent. A large amount of phosphorus-containing waste liquid in the production process can be avoided.
Preparation method for catalyzing pyrimidine cyclic hydroxyl chlorination by tetraethylammonium chloride
-
Paragraph 0020-0022, (2020/04/17)
The invention discloses a preparation method for catalyzing pyrimidine cyclic hydroxyl chlorination by tetraethylammonium chloride, which comprises the following steps: (1) adding phosphorus oxychloride into a container, adding tetraethylammonium chloride as a catalyst, adding a pyrimidine cyclic hydroxyl compound, and heating to react; (2) preparing an alkali liquor, cooling to 0 DEG C, and slowly dropwise adding an obtained reaction liquid into the alkali liquor for quenching to obtain a target product. The method has the advantages that the provided pyrimidine cyclic hydroxyl chlorination catalysis method is small in environmental pollution, the obtained product is light in color, the catalysis efficiency is high, and the phosphorus oxychloride recovery pressure is small.
Preparation method of 4-chloro-7H-pyrrolo[2,3-d]pyrimidine
-
Paragraph 0052-0054; 0059-0062; 0063-0064; 0069-0072; 0073-, (2020/07/15)
The invention discloses a preparation method of 4-chloro-7H-pyrrolo[2,3-d]pyrimidine, wherein the preparation method comprises the steps: carrying out alpha-alkylation reaction on ethyl cyanoacetate and 2-chloromethyl-1,3-dioxolane under the actions of a catalyst and alkali to generate 2-cyano-3-(1,3-dioxolyl)ethyl propionate; carrying out a ring closing reaction on 2-cyano-3-(1,3-dioxolyl)ethyl propionate and formamidine acetate under the action of alkali, and then carrying out hydrolysis ring closing by virtue of hydrochloric acid, so as to obtain 4-hydroxy-7H-pyrrolo[2,3-d]pyrimidine; carrying out a reaction of 4-hydroxy-7H-pyrrolo[2,3-d]pyrimidine under the action of a chlorination reagent, and generating 4-chloro-7H-pyrrolo[2,3-d]pyrimidine. The raw materials adopted in the method arecheap and easy to obtain, and the synthesis method is simple to operate, mild in reaction condition, low in equipment requirement and suitable for industrial large-scale production.
Method for synthesizing 4 -chloropyrropyrimidine compound (by machine translation)
-
Paragraph 0025; 0030, (2020/08/09)
The invention relates to a synthesis method of 4 -lopyrrolopyrimidine compound, which comprises the following steps: mixing 4 -hydroxypyrrolopyrimidine, phosphorus oxychloride and organic base in a temperature range &at;timetimewise and removing excess ethanol to obtain 3 - 7-amino-4 -iodopyrrolopyrimidine; thirdly, dissolving the product 4 -amino-4 -methyl pyrrolopyrimidine in DMF at room temperature and then drying and concentrating 4 -aminopyrrolopyridine. 4 -aminopyrimidine is dissolved in dichloromethane and then subjected to a heat preservation reaction to get -5 -aminopyrrolopyrimidine; and the mixture is dried to remove the solid insoluble matter and is dried and concentrated to yield 12 hours-aminopyrroyrimidine after the heat preservation reaction is carried out; and the solvent is evaporated to remove the solid insoluble matter and is dried and concentrated to remove the solid insoluble matter 4 -5 -7. (by machine translation)
Preparation method of 4-chlorin-7H-pyrrolo[2,3-d]pyrimidine
-
Paragraph 0063-0066, (2019/11/13)
The invention provides a preparation method of 4-chlorin-7H-pyrrolo[2,3-d]pyrimidine. The preparation method comprises the following steps that in a solvent A, under the action of a catalyst, a compound of a formula II and a compound of a formula III of a methylene reagent are subjected to condensation reaction to obtain a compound of a formula IV; in a solvent B, under the action of alkali, the compound of the formula IV and a formamidine salt are subjected to addition condensation cyclization reaction, elimination reaction to obtain the 4-chlorin-7H-pyrrolo[2,3-d]pyrimidine (I). The preparation method of the 4-chlorin-7H-pyrrolo[2,3-d]pyrimidine is cheap and easy in raw material obtaining, simple in preparation method, easy to operate, small in the amount of waste water acid, safe and environmentally friendly and low in cost; and meanwhile, the preparation method is high in yield and high in selectivity, and less in side reactions.
Method for preparing 4-chloro-7H-pyrrolo[2,3-d] pyrimidine
-
Paragraph 0016; 0020-0021, (2019/10/29)
The invention provides a method for preparing 4-chloro-7H-pyrrolo[2,3-d] pyrimidine. The method comprises the following steps: (1) enabling a compound of a formula (I) shown in the specification to react with ammonium hydroxide in a dichloromethane solvent so as to be converted into a compound of a formula (II) shown in the specification; (2) enabling the compound of the formula (II) to react under catalysis of sodium periodate and a transition metal ruthenium so as to obtain a compound of formula (III) shown in the specification; and (3) under an acid condition, performing a ring-closure reaction on the compound of the formula (III) self so as to generate a target product, namely the 4-chloro-7H-pyrrolo[2,3-d] pyrimidine. Initial raw materials for preparing the 4-chloro-7H-pyrrolo[2,3-d]pyrimidine by using the method are easy to obtain, waste liquids are easy to treat in the reaction process, reaction conditions at different steps are gentle, purification is easy to implement, the operation is simple and feasible, and the yield is high.